Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast and ovarian cancer
{{output}}
Purpose of review: Breast cancer remains a leading cause of cancer-related morbidity and mortality worldwide. One of the most significant advances in treatment has been the evolution of human epidermal growth factor receptor 2 (H... ...
